Search Icon
Search Icon
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public Health Open Journal of Preventive Medicine

Improving Maternal Mortality: Comprehensive Reporting for All Pregnancy Outcomes

Abstract

Objective:

To demonstrate the impact of inadequate standardization and population coverage on the ability to measure and improve maternal mortality in the United States.

Data Sources:

The CDC Wonder system for the years 2000-2015 using the following definitions of maternal mortality and associated ICD-CM-10 codes: 1) Maternal deaths up to 42 days after delivery (A34, O00-O99, except O96-O97); 2) Maternal deaths within one year after delivery (A34, O00-O99, except O97); 3) All maternal deaths (A34, O00-O99).

Study Design:

For each year between 2000-2015, we provided maternal deaths, live births, and calculated maternal mortality ratios (MDR). For deaths within 42 days, we also calculated adjusted mortality ratios (ADR).

Principal Findings:

Maternal mortality comparisons which utilize inconsistent definitions and apply non-validated statistical adjustments produce specious results.

Conclusions:

Variation and inconsistency in definitions, coding, and other reporting anomalies render the current aggregated vital statistics on maternal mortality inadequate for accurate trending and service impact studies. The definition of maternal mortality must be expanded to all outcomes of pregnancy: births, induced abortions, and natural fetal losses.

 

Read Complete Article

Latest Posts

October 6, 2026 A magnifying glass rests on three wooden blocks that spell out FDA, symbolizing a review of the REMS modification. A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Ultrasound image showing the side profile of a human baby Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 A sign for the FDA featuring the agency’s logo and circular seals in front of a brick government building, where clinical guidance for mifepristone REMS is often determined. Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

You Might Also Be Interested In

A graphic showing an outline of Kentucky with the text KENTUCKY ABORTION STATISTICS centered over it, detailing 2022 abortion data.

Abortion Reporting: Kentucky (2025)

An outline of the state of Alabama with the text ALABAMA ABORTION STATISTICS centered over it, reflecting current abortion reporting.

Abortion Reporting: Alabama (2025)

Text reading Virginia Abortion Statistics, providing 2022 abortion data, centered over a light gray silhouette of the state of Virginia inside a white circle on a blue background.

Abortion Reporting: Virginia (2024)

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image